Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

Quantum Strategy's David Roche says Europe's defense spending needs to increase by at least $200 billion as he discusses the ...

Though David says his ankle weights warmup is “unscientific” and does not recommend this practice to the athletes he coaches, ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

Posay, the dermatologist-recommended leader in skincare, is thrilled to announce its partnership with the BNP Paribas Open as ...

Former Walton Family Enterprises CEO expands BanyanGlobal’s family office capabilities as the preeminent advisor to owners of ...

The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

Submission is supported by positive results from the Phase III REGENCY trial, which demonstrated that nearly half of patients ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

Australian tennis great Fred Stolle, who won two Grand Slam titles in the 1960s and later enjoyed a lengthy career as a ...

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

Roche’s Genentech unit has received approval from the US Food and Drug Administration (FDA) for TNKase (tenecteplase) in ...